Launch of TerugBetaalRegeling Veltassa®
The health insurer does not fully reimburse Veltassa® 8.4g. The producer of this medicine has therefore asked TBR Nederland to reimburse the costs of the…
Amendment to TerugBetaalRegeling Forxiga® and Xigduo®
The health insurer does not yet reimburse this medication as monotherapy or for specific combination treatment. The producer of…
Launch of TerugBetaalRegeling Lokelma®
The health insurer does not fully reimburse Lokelma® 5g and 10g. The producer of this medicine has therefore asked TBR Nederland to reimburse the…
Relaunch of TerugBetaalRegeling Plenadren®
The health insurer does not fully reimburse Plenadren® 5mg and 20mg. The producer of this medicine has therefore asked TBR Nederland to reimburse the…
Launch of TerugBetaalRegeling Elvanse®
The health insurer does not fully reimburse Elvanse® 20, 30, 50 and 70mg. The producer of this medicine has therefore asked TBR Nederland to…
Keeping medicines affordable
From 2019, the invoice for the Personal contribution will be automatically forwarded by the pharmacist to the health insurer. The health insurer will then send an…
